JPMorgan Chase & Co’s Sonnet BioTherapeutics SONN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2
| Closed | -$33 | – | 6658 |
|
|
2023
Q4 | $33 | Buy |
+2
| New | +$33 | ﹤0.01% | 6225 |
|
|
2023
Q3 | – | Sell |
-170
| Closed | -$14.7K | – | 6642 |
|
|
2023
Q2 | $14.7K | Buy |
+170
| New | +$14.7K | ﹤0.01% | 5106 |
|
|
2022
Q2 | – | Sell |
-6
| Closed | -$5K | – | 5888 |
|
|
2022
Q1 | $5K | Buy |
+6
| New | +$5K | ﹤0.01% | 5504 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5075 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4995 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4942 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4267 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4122 |
|